TORONTO, Jan. 5, 2018 /CNW/ - Syncordia Technologies and Healthcare Solutions, Corp. (TSXV: SYN) ("Syncordia") is pleased to provide an update on its refinancing efforts with the signing of a debt term sheet for up to $16.5million.
Terms of the debt term sheet will be finalized pending final diligence, which will take place over the coming weeks and months. The debt term sheet has a four (4) year term and will involve a mezzanine level coupon with accompanying warrants. Final terms will be established based on operational and financial diligence and the final capital structure, as Syncordia plans to compliment this term sheet with an equity round of financing. Completion of the new debt structure will also be subject to customary approvals including lender approval, final documentation and TSX Venture approval.
About Syncordia Technologies and Healthcare Solutions, Corp. dba Syncordia Software
Syncordia Software has a portfolio investment management approach to its growth by partnering with strong companies with a focus on healthcare. We like to partner with well run businesses that have established free cash flow and a strong propensity to growth with meaningful easy to use software and IT service solutions. We are a software and information technology services company with a focus on healthcare. We are focused on using our proprietary software suite as an accelerator for growth. Our growth strategy is to acquire healthcare oriented software and information technology service companies with great teams and improve their profitability by increasing revenues and improving operating efficiencies working with the local management teams. Syncordia will leverage proprietary software to manage scale, drive better customer experiences and enhance margins while driving a competitive sustainable profile.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements
Certain statements herein may be "forward looking" statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Syncordia or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees with respect to any potential debt and/or equity offering or of future performance or results, and will not necessarily be accurate indications of whether such transactions will be consummated or results will be achieved. A number of factors could cause such transactions to not be completed or actual results to vary significantly from the results discussed in the forward-looking statements. These forward-looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and we assume no obligation, except as required by law, to update any forward-looking statements to reflect new events or circumstances.
SOURCE Syncordia Technologies and Healthcare Solutions, Corp.
For further information: Michael Franks, Chief Executive Officer, (647) 949-2663, [email protected]